|
Market Cap (3-Jul) $176,237,888 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.009 |
RAP released this announcement to the ASX on 26 October 2021, 9:20. The announcement is marked as price sensitive, and is 2 page(s) in length and 109.26kb in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.266% short sold according to ASIC data. It was ranked the 358th most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| COVID-19 Clinical Studies Update | 26 October 2021, 9:20 |
| Notice under ASX Listing Rule 3.13.1 | 12 October 2021, 17:29 |
| ResApp announces FDA 510(k) submission for SleepCheckRx | 11 October 2021, 9:19 |
| Notification regarding unquoted securities - RAP | 1 October 2021, 17:44 |
You must be logged in to post a reply.
ResApp Health 